Solana
HSDT | NASDAQ
$3.37
+$0.26 (+8.36%)
Sep 22, 2026, 12:48 PM ET · Market open
+8.36%
(1D)Rating
Updated: Sep 9, 2026Key Statistics
Market Data
Market Cap $196.76M
1D Range
3.08 3.42
52W Range
1.19 20.50
Valuation (TTM)
PE -0.10
PB 1.10
EV/EBITDA -0.69
Valuation (NTM)
Forward PE 0.00
Forward PEG 0.00
Price Target $3.50
Cash Flow
FCF Yield -14.8%
SBC Adj. FCF Yield -19.4%
SBC Impact -30.8%
Margins
Gross Margin 95.5%
Operating Margin -200.5%
FCF Margin -223.2%
Growth (CAGR)
Revenue 3Y | 5Y 142.7% |
90.8%
Dil EPS 3Y | 5Y -84.5% |
56.0%
FCF 3Y | 5Y -50.9% |
-15.3%
Returns
ROA -89.3%
ROE -122.8%
ROIC -13.9%
Financial Health
Net Cash
$3.65M
Current Ratio 13.31
Interest Coverage -355.90
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-...
Sector Financial Services
Industry Asset Management
Employees 21
IPO Date Jun 26, 2014
Website www.solanacompany.co
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$3.50
Upside
+3.86%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove HSDT